KPN Ventures has invested in Personal MedSystems GmbH, a German maker of mobile heart-monitoring services. The investment is in line with KPN Venture’s strategy to invest in digital health initiatives and build partnerships that bring ICT innovations to the Dutch market.
Aided by mobile technology, self-monitoring is on the rise, both for preventive purposes and to optimize treatment of diagnosed patients. Personal MedSystems is tapping into that trend with the development of CardioSecur®, a smartphone-based ECG device that gives instant feedback on possible heart failure symptoms when and wherever they occur and shows the user a recommendation on what to do next.
The company was founded in 2008 by Dr. Markus Riemenschneider and Felix Brand. They worked with cardiologists and leading hospitals in Germany to develop the certified CardioSecur device, which provides a clinical-grade ECG and actionable feedback. CardioSecur is very simple to use, also by general practitioners and by people at home.
Herman Kienhuis, managing director KPN Ventures, says: “We see great potential for digital and mobile technologies to improve the quality of healthcare while reducing the cost. Personal MedSystems has developed such an innovation bringing great value to people suffering from heart problems and to cardiologists. In addition to financially supporting its growth, KPN will help Personal MedSystems in bringing CardioSecur to the Dutch market as well.”
We see great potential for digital and mobile technologies to improve the quality of healthcare while reducing the cost
KPN Ventures is lead investor in a financing round into Personal MedSystems totalling EUR 5 million. Besides KPN Ventures, other investors in this round include the Sino-German High-Tech Fund and the NRW-Bank. Existing shareholders in the company, Seventure Partners and High-Tech Gründer Fund, also participated in the round. Personal MedSystems will use the capital to finance future growth and innovation.
KPN believes innovative ICT solutions can contribute significantly to improving healthcare services, lowering their cost to society and increasing people’s autonomy even in the face of illness or old age.
In this respect, the majority of general practitioners and pharmacies in the Netherlands already make use of KPN’s E-Zorg network to communicate in a safe and confidential manner about patients and their healthcare services. In the field of monitoring at a distance, KPN’s remote heart monitoring-service enables patients to do an ECG at home and share it with health care professionals – saving time and travel for routine check-ups while allowing for follow-up if needed. Already more than 2,200 general practitioners make use of this monitoring service resulting in approximately 14,000 remote ECG’s annually.
Personal MedSystems develops and markets products and services for mHealth cardiac care, which are unique in their innovative depth, user friendliness and profound data generating capacity. Its 15-lead ECG CardioSecur® sensor services with only for 4 electrodes and a 50 gram light unit linking to a smartphone form the means for building an unrivaled smart data platform that allows pattern analysis and predictive value generation for critical cardiac events in the future. Personal MedSystems GmbH is based in Frankfurt am Main, Germany.
KPN Ventures © 2024. All Rights Reserved
